Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,063 public trials 1,834 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

NCT06692738

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Anaheim, California, United States
  • Research Site Beverly Hills, California, United States
View all 312 locations
View Trial Details
Recruiting

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

NCT06686771

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Saint Mary's Hospital and Regional Medical Center Grand Junction, Colorado, United States
View all 75 locations
View Trial Details
Recruiting

A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

NCT07699328

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Oncology Clinical Research Unit Bedford Park, South Australia, Australia
  • Monash Medical Centre Clayton Clayton, Victoria, Australia
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • AP-HM Hôpital Nord Marseille, Bouches-du-Rhône, France
View all 29 locations
View Trial Details
Recruiting

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

NCT06726148

Conditions
Advanced CCNE1-amplified Solid Tumors, Advanced HR+/HER2- Breast Cancer, Breast Diseases, +14 more
Locations
  • University of California LA Los Angeles, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • WA Uni School Of Med St Louis, Missouri, United States
View all 33 locations
View Trial Details
Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

NCT05877599

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +47 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Newport Beach, California, United States
  • Research Site Santa Monica, California, United States
View all 18 locations
View Trial Details

Related conditions